173 related articles for article (PubMed ID: 26823712)
1. Knockdown of PFTK1 inhibits tumor cell proliferation, invasion and epithelial-to-mesenchymal transition in pancreatic cancer.
Zheng L; Zhou Z; He Z
Int J Clin Exp Pathol; 2015; 8(11):14005-12. PubMed ID: 26823712
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of PFTAIRE Protein Kinase 1 (PFTK1) Inhibits Proliferation, Invasion, and EMT in Colon Cancer Cells.
Zhu J; Liu C; Liu F; Wang Y; Zhu M
Oncol Res; 2016; 24(3):137-44. PubMed ID: 27458094
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of PFTK1 Expression by RNAi Inhibits the Proliferation and Invasion of Human Non-Small Lung Adenocarcinoma Cells.
Liu MH; Shi SM; Li K; Chen EQ
Oncol Res; 2016; 24(3):181-7. PubMed ID: 27458099
[TBL] [Abstract][Full Text] [Related]
4. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
Sun Y; Zhu Q; Yang W; Shan Y; Yu Z; Zhang Q; Wu H
J Cell Biochem; 2019 Mar; 120(3):3874-3886. PubMed ID: 30474270
[TBL] [Abstract][Full Text] [Related]
5. PFTK1 Promotes Gastric Cancer Progression by Regulating Proliferation, Migration and Invasion.
Yang L; Zhu J; Huang H; Yang Q; Cai J; Wang Q; Zhu J; Shao M; Xiao J; Cao J; Gu X; Zhang S; Wang Y
PLoS One; 2015; 10(10):e0140451. PubMed ID: 26488471
[TBL] [Abstract][Full Text] [Related]
6. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
Lu WD; Zuo Y; Xu Z; Zhang M
World J Gastroenterol; 2015 Apr; 21(15):4564-73. PubMed ID: 25914465
[TBL] [Abstract][Full Text] [Related]
7. HPIP promotes thyroid cancer cell growth, migration and EMT through activating PI3K/AKT signaling pathway.
Wang SC; Chai DS; Chen CB; Wang ZY; Wang L
Biomed Pharmacother; 2015 Oct; 75():33-9. PubMed ID: 26463629
[TBL] [Abstract][Full Text] [Related]
8. WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer.
Huang S; Huang C; Chen W; Liu Y; Yin X; Lai J; Liang L; Wang Q; Wang A; Zheng C
Int J Oncol; 2018 Aug; 53(2):672-684. PubMed ID: 29845225
[TBL] [Abstract][Full Text] [Related]
9. α-Mangostin suppresses the viability and epithelial-mesenchymal transition of pancreatic cancer cells by downregulating the PI3K/Akt pathway.
Xu Q; Ma J; Lei J; Duan W; Sheng L; Chen X; Hu A; Wang Z; Wu Z; Wu E; Ma Q; Li X
Biomed Res Int; 2014; 2014():546353. PubMed ID: 24812621
[TBL] [Abstract][Full Text] [Related]
10. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms.
Wang L; Wu H; Wang L; Zhang H; Lu J; Liang Z; Liu T
Cancer Lett; 2017 Jul; 398():24-36. PubMed ID: 28400334
[TBL] [Abstract][Full Text] [Related]
11. ERas regulates cell proliferation and epithelial-mesenchymal transition by affecting Erk/Akt signaling pathway in pancreatic cancer.
Liu Y; Qin P; Wu R; Du L; Li F
Hum Cell; 2020 Oct; 33(4):1186-1196. PubMed ID: 32700262
[TBL] [Abstract][Full Text] [Related]
12. Upregulated PFTK1 promotes tumor cell proliferation, migration, and invasion in breast cancer.
Gu X; Wang Y; Wang H; Ni Q; Zhang C; Zhu J; Huang W; Xu P; Mao G; Yang S
Med Oncol; 2015 Jul; 32(7):195. PubMed ID: 26033031
[TBL] [Abstract][Full Text] [Related]
13. PTEN/PI3K/mTOR/B7-H1 signaling pathway regulates cell progression and immuno-resistance in pancreatic cancer.
Zhang Y; Zhang J; Xu K; Xiao Z; Sun J; Xu J; Wang J; Tang Q
Hepatogastroenterology; 2013 Oct; 60(127):1766-72. PubMed ID: 24624456
[TBL] [Abstract][Full Text] [Related]
14. PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells.
Ge L; Wang H; Xu X; Zhou Z; He J; Peng W; Du F; Zhang Y; Gong A; Xu M
J Cell Mol Med; 2020 Jan; 24(2):1969-1979. PubMed ID: 31851779
[TBL] [Abstract][Full Text] [Related]
15. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of TMPRSS3 inhibits gastric cancer cell proliferation, invasion and EMT via regulation of the ERK1/2 and PI3K/Akt pathways.
Li SL; Chen X; Wu T; Zhang XW; Li H; Zhang Y; Ji ZZ
Biomed Pharmacother; 2018 Nov; 107():841-848. PubMed ID: 30142546
[TBL] [Abstract][Full Text] [Related]
17. TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways.
Ha GH; Park JS; Breuer EK
Cancer Lett; 2013 May; 332(1):63-73. PubMed ID: 23348690
[TBL] [Abstract][Full Text] [Related]
18. Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo.
Li Y; Liu H; Lai C; Su Z; Heng B; Gao S
Oncol Rep; 2015 May; 33(5):2319-30. PubMed ID: 25812440
[TBL] [Abstract][Full Text] [Related]
19. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
Lu W; Xu Z; Zhang M; Zuo Y
Int J Clin Exp Pathol; 2014; 7(10):7286-96. PubMed ID: 25400827
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial-Mesenchymal Transition: Enhanced Efficacy when Combined with Gemcitabine.
Wei R; Penso NEC; Hackman RM; Wang Y; Mackenzie GG
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31405071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]